Healthcare >> CEO Interviews >> July 31, 2000
JACK J. LUCHESE has a twenty-seven year career in management, having
joined CytRx in March of 1989, where he serves as President and CEO.
Prior to his appointment at CytRx, Mr. Luchese served as Vice President
and General Manager of Armour Pharmaceutical Company, a wholly-owned
subsidiary of Rhone-Poulenc Rorer. At Armour, he helped introduce the
drug Monoclate' and guided the firm through a major refocusing effort,
leading to improved sales and earnings. In addition, he served as
corporate Vice President of business development, responsible for
licensing, mergers and acquisitions. Mr. Luchese also spent 15 years
with Johnson & Johnson in various capacities, including business
development, licensing, sales, new product marketing and finance. Mr.
Luchese received his Master's degree in Business Administration from
Fairleigh Dickenson University and his Bachelor's degree in Business
from Montclair University. Profile
the company?
Mr. Luchese: CytRx is a small biopharmaceutical company. We're located
in Norcross, Georgia, and our
